Effect of amlodipine on hemodynamic and endocrine responses to mental stress

American Journal of Hypertension

Volumn 13, Issue 5 II SUPPL., 2000, Pages 518-522

  Spence, J David ^a,b   Munoz, Claudio ^a   Huff, Murray W ^a   Tokmakjian, Sonya ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Amlodipine; Blood pressure; Hemodynamics; Mental stress

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIHYDROPYRIDINE; HORMONE; LIPID; LIPOPROTEIN; NISOLDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PLACEBO;

ADULT; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HORMONE RELEASE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MENTAL STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; TITRIMETRY; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; AGED; AMLODIPINE; BIOLOGICAL MARKERS; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOCRINE SYSTEM; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; NOREPINEPHRINE; STRESS, PSYCHOLOGICAL;

EID: 0034027957     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Friedman M, Rosenman RH: Type A behavior and your heart. New York: Fawcett Books, 1974.
2. Corse CD, Manuck SB, Cantwell JD, Giordani B, Matthews KA: Coronary-prone behavior pattern and cardiovascular response in persons with and without coronary heart disease. Psychosomatic Medicine 1982;44: 449-459.
3. Ragland DR, Brand RJ: Type A behavior and mortality from coronary heart disease. N Engl J Med 1988;318: 65-69.
4. Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG (the MILIS study): Analysis of possible triggers of acute myocardial infarction (The MILIS Study). Am J Cardiol 1990;66:22-27.
5. Manuck SB, Krantz DS: Psychophysiologic reactivity in coronary heart disease and essential hypertension, in Matthews KA, Weiss SB, Detre T, Dembroski TM, Falkner B, Manuck SB, Williams RB (eds): Handbook of Stress, Reactivity, and Cardiovascular Disease. John Wiley & Sons, New York, 1986, pp 11-34.
6. Manuck SB, Kaplan JR, Adams MR, Clarkson TB: Studies of psychosocial influences on coronary artery atherosclerosis in cynomolgus monkeys. Health Psychol 1988;7:113-124.
7. Manuck SB, Olsson G, Hjemdahl P, Rehnqvist N: Does cardiovascular reactivity to mental stress have prognostic value in post-infarction patients? A pilot study. Psychosomat Med 1992;54:102-108.
8. Spence JD, Barnett PA, Manuck SB, Jennings JR: Psychological stress and progression of carotid atherosclerosis. J Hypertens 1997;15:49-55.
9. Lichten PR, Hugenholz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW: Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990;335: 1109-1113.
10. Ludwig J, Gerhardt T, Halbrugge T, Walter T, Heidbreder E, Graefe K-H: Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives. J Hum Hypertens 1990;4:693-701.
11. Faulkner JK, McGibney D, Chasseaud JL, Perry JL, Taylor IW: The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmac 1986;22:21-25.
12. Willemsen JJ, Ross HA, Jacobs MC, Lenders JW, Thien T, Swinkels LM, Benraad TJ: Highly sensitive and specific HPLC with fluorimetric detection for determination of plasma epinephrine and norephinephrine applied to kinetic studies in humans. Clin Chem 1995;41: 1455-1460.
13. Spence JD, Bass M, Robinson HC, Cheung H, Melendez LJ, Arnold JMO, Manuck SB: Prospective study of ambulatory monitoring and echocardiography in borderline hypertension. Clin Invest Med 1991;14,3:241-250.
14. Spence JD: Cerebral consequences of hypertension, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, Second Edition. Raven Press, New York, 1995, pp 741-753.
15. Messerli FH, Opie LH: Nifedipine and mortality: grave defects in the dossier. Circulation 1995;92:1068-1073.